NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/02/2025
Voltar para busca
Dado oficial do USPTO
ABSIEVE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
12/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
11/04/2016
Data de registro
15/08/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/02/2025
Última transação
12/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
16
Localização do titular
Plzen, CZ
Examinador
O'ROURKE, JONATHAN
Localização atual
Historical data usage
Titulares e representantes
Titulares
A. S. (pessoa física)
Representantes
Karen L. Elbing CLARK & ELBING LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological services and research projects for the preparation of peptide and antibody librariesfor identification and characterization of binding moleculesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparationidentification and characterisation of peptides and antibodiesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation and identification of recombinant antibodiessingle-chain antibodiesdiabodiestandabsflexibodiestriabodiestetrabodiesbivalent antibodiesmultivalent antibodieswhole immunoglobulinsantibody fragmentsin particular Fab and scFv fragmentsof nucleic acid sequences coding for these moleculesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to antibody discoveryscientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of naturalengineered and immunized librariesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to screening of antibody librariesscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to phage displayphage panning and yeast display vectorsscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection processscientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectorsscientific research and analysis in the field of antibody discovery; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic applicationscientific research and analysis in the field of antibody research and drug design
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/02/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/08/2024
E815
TEAS SECTION 8 & 15 RECEIVED
08/02/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
15/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
15/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/05/2017
PUBO
PUBLISHED FOR OPPOSITION
30/05/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/04/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/03/2017
GNRT
NON-FINAL ACTION E-MAILED
16/03/2017
CNRT
NON-FINAL ACTION WRITTEN
16/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/02/2017
ALIE
ASSIGNED TO LIE
16/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/08/2016
GNRT
NON-FINAL ACTION E-MAILED
02/08/2016
CNRT
NON-FINAL ACTION WRITTEN
02/08/2016
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
29/07/2016
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
29/07/2016
DOCK
ASSIGNED TO EXAMINER
26/07/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/04/2016
NWAP
NEW APPLICATION ENTERED
14/04/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ABSIEVE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.